Apollomics, Inc Announces Enrollment of First Patient in Phase 1 Clinical Trial of APL-106 (uproleselan injection) in China Apollomics, Inc. Mar 04, 2021 11:30 HKT/SGT Read More
Alvotech and Cipla Gulf Expand Partnership for Commercialization of Biosimilars in Australia and New Zealand Alvotech Mar 04, 2021 10:26 HKT/SGT Read More
Eisai to Support Construction of Screening Framework for the Novel Coronavirus Infection in Kenya Eisai Mar 04, 2021 08:12 HKT/SGT Read More
国际罕见病日:贝康医疗宣布为1000个罕见病家庭提供大型公益资助活动,全球首款遗传病阻断试剂盒进入临床试验! Suzhou Basecare Medical Corporation Limited Mar 01, 2021 08:36 HKT/SGT Read More
國際罕見病日:貝康醫療宣佈為1000個罕見病家庭提供大型公益資助活動,全球首款遺傳病阻斷試劑盒進入臨床試驗! Suzhou Basecare Medical Corporation Limited Mar 01, 2021 08:35 HKT/SGT Read More
在日米国商工会議所とマッキンゼー・アンド・カンパニー日本支社が、デジタル改革を通じて日本の生産性と成長を推進する11の「大胆な一手」を提案 The American Chamber of Commerce in Japan (ACCJ) Feb 25, 2021 11:30 JST Read More
Eisai: MHLW Grants Orphan Drug Designation in Japan to Novel FGF Receptor Selective Tyrosine Kinase Inhibitor E7090 Eisai Feb 22, 2021 14:40 HKT/SGT Read More
エーザイ、新規線維芽細胞増殖因子(FGF)受容体選択的チロシンキナーゼ阻害剤E7090が日本においてFGFR2融合遺伝子を有する切除不能な胆道がんを予定される効能・効果として厚生労働省より希少疾病用医薬品に指定 Eisai Feb 22, 2021 14:00 JST Read More
Eisai Receives Corporate Philanthropy Award for Its Efforts to Realize Human Health Care (hhc) Philosophy Eisai Feb 22, 2021 12:11 HKT/SGT Read More